Evidence map›Paper›PMID 39192018›Full record

ArticleArchives of toxicology2024

CYP2E1 in 1,4-dioxane metabolism and liver toxicity: insights from CYP2E1 knockout mice study.

Yewei Wang, Georgia Charkoftaki, David J Orlicky, Emily Davidson, Reza Aalizadeh, Ning Sun, Gary Ginsberg, David C Thompson, Vasilis Vasiliou, Ying Chen

Abstract read
In one paragraph

Article in Archives of toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The Functional Identification of theInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yewei WangDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA.
Georgia CharkoftakiDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA.
David J OrlickyDepartment of Pathology, School of Medicine, Anschutz Medical Center, University of Colorado, University of Colorado, Aurora, CO, 80045, USA.
Emily DavidsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA.
Reza AalizadehDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA.
Ning SunDepartment of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA.
Gary GinsbergDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA.
David C ThompsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA.
Vasilis VasiliouDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA. vasilis.vasiliou@yale.edu.
Ying ChenDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, 06510, USA. ying.chen@yale.edu.ORCID 0000-0003-1960-419X

Funding

Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
SENSORS FOR WATER CONTAMINANT DETECTION AND MONITORINGP42ES033815 · NIEHS · YALE UNIVERSITY · PI Nicole Deziel · 2022 to 2026
$9.5M
Mouse Models for Alcohol Metabolism and Tissue InjuryR24AA022057 · NIAAA · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2013 to 2022
$4.5M
Redox Regulation of O-GlcNAcylation Signaling in the Pathogenesis of Alcoholic Fatty Liver DiseaseR01AA028859 · NIAAA · YALE UNIVERSITY · PI Ying Chen · 2022 to 2026
$1.9M
NIAAA NIH HHS R01 AA028859NIAAA NIH HHS R01AA028859NIAAA NIH HHS R24 AA022057NIAAA NIH HHS R24AA022057NIDDK NIH HHS P30 DK034989NIEHS NIH HHS P42 ES033815NIEHS NIH HHS P42ES033815
6 · The paper itself

Abstract

1,4-Dioxane (DX), an emerging water contaminant, is classified as a Group 2B liver carcinogen based on animal studies. Understanding of the mechanisms of action of DX liver carcinogenicity is important for the risk assessment and control of this environmental pollution. Previous studies demonstrate that high-dose DX exposure in mice through drinking water for up to 3 months caused liver mild cytotoxicity and oxidative DNA damage, a process correlating with hepatic CYP2E1 induction and elevated oxidative stress. To access the role of CYP2E1 in DX metabolism and liver toxicity, in the current study, male and female Cyp2e1-null mice were exposed to DX in drinking water (5000 ppm) for 1 week or 3 months. DX metabolism, redox and molecular investigations were subsequently performed on male Cyp2e1-null mice for cross-study comparisons to similarly treated male wildtype (WT) and glutathione (GSH)-deficient Gclm-null mice. Our results show that Cyp2e1-null mice of both genders were resistant to DX-induced hepatocellular cytotoxicity. In male Cyp2e1-null mice exposed to DX for 3 months, firstly, DX metabolism to β-hydroxyethoxyacetic acid was reduced to ~ 36% of WT levels; secondly, DX-induced hepatic redox dysregulation (lipid peroxidation, GSH oxidation, and activation of NRF2 antioxidant response) was substantially attenuated; thirdly, liver oxidative DNA damage was at a comparable level to DX-exposed WT mice, accompanied by suppression of DNA damage repair response; lastly, no aberrant proliferative or preneoplastic lesions were noted in DX-exposed livers. Overall, this study reveals, for the first time, that CYP2E1 is the main enzyme for DX metabolism at high dose and a primary contributor to DX-induced liver oxidative stress and associated cytotoxicity. High dose DX-induced genotoxicity may occur via CYP2E1-independent pathway(s), potentially involving impaired DNA damage repair.

Indexed as

Cytochrome P-450 CYP2E1DioxanesLiverMice, KnockoutOxidative StressAnimalsCarcinogensChemical and Drug Induced Liver InjuryDNA DamageFemaleGlutathioneMaleMiceMice, Inbred C57BL1,4-dioxaneCarcinogenscytochrome P-450 2E1, mouseCytochrome P-450 CYP2E1DioxanesGlutathioneCytochrome p450Liver carcinogenesisOxidative DNA damageOxidative stressWater contaminant

Identifiers

PMID39192018
PMCPMC11500436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.